Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗凝药(Anticoagulants);共病现象(Comorbidity);体外膜氧合作用(Extracorporeal Membrane Oxygenation);女(雌)性(Female);出血(Hemorrhage);肝素(Heparin);医院死亡率(Hospital Mortality);人类(Humans);住院病人(Inpatients);男(雄)性(Male);医疗无效(Medical Futility);中年人(Middle Aged);氧吸入疗法(Oxygen Inhalation Therapy);血小板活化(Platelet Activation);血小板聚集抑制剂(Platelet Aggregation Inhibitors);嘌呤能P2Y受体拮抗剂(Purinergic P2Y Receptor Antagonists);受体, 嘌呤能P2Y12(Receptors, Purinergic P2Y12);呼吸, 人工(Respiration, Artificial);血栓形成(Thrombosis);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1001/jama.2021.23605
PMID
35040887
发布时间
2024-08-21
- 浏览4

JAMA
227-236页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文